Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Data(s) |
01/12/2015
|
---|---|
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Strefford , J C , Kadalayil , L , Forster , J , Rose-Zerilli , M J , Parker , A , Lin , T T , Heppel , N , Norris , K , Gardiner , A , Davies , Z , Gonzalez de Castro , D , Else , M , Steele , A J , Parker , H , Stankovic , T , Pepper , C , Fegan , C , Baird , D , Collins , A , Catovsky , D & Oscier , D G 2015 , ' Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial. ' Leukemia , vol 29 , no. 12 , pp. 2411-2414 . DOI: 10.1038/leu.2015.217 |
Palavras-Chave | #Disease Progression #Genes, p53 #Humans #Immunoglobulin Heavy Chains #Leukemia, Lymphocytic, Chronic, B-Cell #Mutation #Telomere |
Tipo |
article |